1. U.S. Colorectal Cancer Therapeutics Markets New Therapeutics Boost Survival Rates “With as many as 20 products currently in development, there will be a plethora of therapeutic solutions available to physicians in the near future. Immunotherapies such as monoclonal antibodies, angiogenesis inhibitors, and gene therapies will enter the market from 2002 onward.” Pharmaceuticals Analyst Team Frost & Sullivan

2. Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics’ and emerging applications in the colorectal cancer therapeutics markets Market sizing and competitive analysis Market forecasts and opportunity analysis Quarterly assessments End user analysis within each report Key Features

3. Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans What We Offer

4. Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the market’s unmet needs Investment Community Analyze long-term strategies of companies Determine which participants will outperform the competition Assess attractiveness of investing in the market Who Will Benefit?

5. Aphton Corp. Astra-Zeneca Pharmaceutical Aventis-Pasteur, Inc. AVI Biopharma Axcan Pharma, Inc. Bristol-Myers Squibb Celgene Cell Pathways Centocor Cytran, Inc. Genentech Glaxo-Smithkline Hoffman La Roche, Inc. Imclone Systems, Inc. Immunex Corp. Immunogen, Inc. Immunomedics, Inc. Matrix Pharmaceutical, Inc. Myraid Genetics Oxigene Pharmacia Corp. Safe Science Sanofi-Synthelabo SuperGen, Inc. Titan Pharma Tularik Pharma Key Market Participants

6. Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information